The announcement comes a day after its expansion into Brazil was unveiled.
"Sustained growth over several quarters demonstrates the viability of our core principles of cutting-edge product development an absolute dedication to servicing our customers,” said co-founder and chief executive Daniel Khesin
The company maintains its ‘edge-of-the art’ development of new molecules and therapies in the personal care sector and its position as the world's innovator of hair re-growth technologies, stating that revenue has been driven by new distribution and new products.
Biotechnology development opportunities
DS Laboratories, Divine Skin's first brand, has also unveiled two new over-the-counter products; Revita.EPS - a treatment to grow eyelashes 25 percent longer in just 4 weeks; and Revita.COR - a hair-growth-stimulating conditioner with bio-adhesive properties.
“We are also most excited about the release of Revita.COR conditioner which we believe establishes new possibilities in biotech development," Khesin continued.
The biotech company claims Revita.COR is the first product in the world to feature technology that allows active ingredients to remain on the scalp even after the product is rinsed off and redefines what is possible in rinse-off applications.
It also stated that future revenue will flow from the recently announced Latin American subsidiary; DS Laboratories do Brasil, which expands Divine Skin in the world's second largest cosmetics market.
Expansion into Brazil
"This is a major milestone in the meteoric growth of Divine Skin worldwide," added Khesin. "We expect Brazilian sales to be visible in 2010 figures and to contribute strongly in 2011 and beyond."
One of the first emerging markets to resume strong growth after the recent downturn, Brazil's economy exceeds all other Latin American countries.
DS Laboratories will begin its Brazilian marketing operations with several level-1 cosmetics, including its Nia radiant-color shampoo and conditioner and Nirena pH-balanced feminine cleanser.
Brazil's regulatory authorities require blind 60-day efficiency tests for level-2 cosmetics such as the company's Oligo.DX advanced cellulite-reducing gel. In recent studies DS Labs claim the product has demonstrated a 90-percent success rate.
By the end of October, the company expects efficiency tests to be completed for its Revita products.
DS Laboratories expect the rest of its products to have completed tests by the end of the year.